David M. Goldenberg mainly focuses on Antibody, Monoclonal antibody, Pathology, Radioimmunotherapy and Cancer. His Antibody research includes themes of Molecular biology, In vivo and Antigen. His research in Monoclonal antibody focuses on subjects like Pharmacology, which are connected to SN-38, Sacituzumab govitecan and Antibody-drug conjugate.
He has included themes like Pharmacokinetics, Carcinoembryonic antigen, Head and neck cancer and Metastasis in his Pathology study. His Radioimmunotherapy study incorporates themes from Gastroenterology, Nuclear medicine, Toxicity, Radiation therapy and Bone marrow. His Cancer research includes elements of Cancer research and Oncology.
Antibody, Internal medicine, Monoclonal antibody, Pathology and Radioimmunotherapy are his primary areas of study. His biological study spans a wide range of topics, including Molecular biology, Cancer research, Antigen and Carcinoembryonic antigen. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Surgery and Oncology.
His studies deal with areas such as In vivo, Biodistribution and Pharmacology as well as Monoclonal antibody. His study of Carcinoma is a part of Pathology. David M. Goldenberg interconnects Nuclear medicine, Radiation therapy, Toxicity and Bone marrow in the investigation of issues within Radioimmunotherapy.
His primary scientific interests are in Internal medicine, Cancer, Surgery, Oncology and Sacituzumab govitecan. His studies in Internal medicine integrate themes in fields like Gastroenterology and Immunology. His Cancer study integrates concerns from other disciplines, such as Cancer research and Epidemiology, Pathology.
His study focuses on the intersection of Cancer research and fields such as Antibody with connections in the field of Molecular biology. His Surgery research incorporates elements of Thyroid and Thyroid cancer. Many of his studies on Oncology apply to Radioimmunotherapy as well.
His main research concerns Internal medicine, Cancer, Sacituzumab govitecan, Pharmacology and Antibody-drug conjugate. His research integrates issues of Gastroenterology, Surgery and Oncology in his study of Internal medicine. The concepts of his Cancer study are interwoven with issues in Cancer research, Epidemiology and Human papillomavirus.
His Cancer research study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning
D.M. Goldenberg;F. DeLand;E. Kim;S. Bennett.
The New England Journal of Medicine (1978)
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
David M. Goldenberg.
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.
Aditya Bardia;Ingrid A Mayer;Linda T Vahdat;Sara M Tolaney.
The New England Journal of Medicine (2019)
Ionization−Reactivity Relationships for Cysteine Thiols in Polypeptides†
Grzegorz Bulaj;Tanja Kortemme;David P. Goldenberg.
Targeted Therapy of Cancer with Radiolabeled Antibodies
David M Goldenberg.
The Journal of Nuclear Medicine (2002)
CYSTIC LYMPH NODE METASTASIS IN PATIENTS WITH HEAD AND NECK CANCER: AN HPV-ASSOCIATED PHENOMENON
David Goldenberg;Shahnaz Begum;William H. Westra;Zubair Khan.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck (2008)
A Novel Method of 18F Radiolabeling for PET
William J. McBride;Robert M. Sharkey;Habibe Karacay;Christopher A. D'Souza.
The Journal of Nuclear Medicine (2009)
Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen
D M Goldenberg;E E Kim;F H DeLand;S Bennett.
Cancer Research (1980)
Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
David M. Goldenberg;Robert M. Sharkey;Giovanni Paganelli;Jacques Barbet.
Journal of Clinical Oncology (2006)
Kinetic role of a meta-stable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor☆
T.E. Creighton;D.P. Goldenberg.
Journal of Molecular Biology (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: